The SGLT2 Inhibitors Market has emerged as a pivotal segment in the pharmaceutical industry, driven by the increasing prevalence of type 2 diabetes and cardiovascular diseases. These innovative medications, which function by inhibiting the sodium-glucose cotransporter 2, are transforming t